Advertising
Showing 1 to 15 of 101 entries
TOP PICK
A leader in managed care. Building out pharmacy benefit manager to become increasingly cost-competitive and vertically integrated. Decent valuation. Yield is 1.06%. (Analysts’ price target is $561.52)
medical services
BUY
They insure 44 million Americans, and are partially insulated from inflation and supply chain problems. Likes it. Growing well. Medicare and Medicaid programs allow ANTM to maintain their margins. UNH has also done very well, but ANTM trades at a lower multiple.
medical services
BUY
Growth vs. value is in play. Companies in healthcare give you earnings stability and predictability, safety. Not an extreme multiple, over $28 EPS this year. Healthcare is a good area, ANTM is a good choice.
medical services
HOLD
UNH is a very good company, but not as good a stock because of valuation. He owns ANTM instead, trading about 6 multiple points less than UNH, with equally good growth metrics. Higher multiple stocks are selling off. Neither has supply chain issues.
medical services
TOP PICK
Health insurance is exciting. Their valuation trades at a decent 15x earnings. He targets $29 EPS this year. Their growth rate is solid double digits. A great area to hide if you worry about inflation. Revenues are protected, because government programs adjust for inflation. They insure 43 million Americans and he predicts 49 million by the end of this year. Aging demographics are a boost. (Analysts’ price target is $490.21)
medical services
PAST TOP PICK
(A Top Pick Feb 11/21, Up 57%) We just don't have this kind of insurance company in Canada. Blue Cross and Blue Shield dominate in about 13 states. More of a value play than UNH, though he owns both. Both executing exceptionally well.
medical services
PAST TOP PICK
(A Top Pick Jan 19/21, Up 39%) Still likes. Trading at 15x earnings, quite inexpensive. Major competitor, UNH, trades 6 points higher. Adding insureds, now up to 43M in the US. Growing well. Expected EPS for 2022 is $29.
medical services
BUY
In the space, he owns ANTM instead of UNH. Both have HMOs and PBMs. ANTM is half the size of UNH, cheaper, and it has as good, if not better, future prospects. 5-year chart shows them running neck-and-neck. Medicare for all is a long way out, given the huge US debt.
medical services
BUY
ANTM vs. UNH He owns ANTM instead of UNH. Valuation of 6-8 multiple points less expensive than UNH. Well managed, growth rates are very good, and medical cost ratios are inline.
medical services
TOP PICK
Healthcare insurance for individuals, governments, corporations. Lets customers get better margins for their healthcare dollar. Growing earnings steadily and dividends over time. Trades at an attractive 13x earnings. Yield is 1.22%. (Analysts’ price target is $433.29)
medical services
PAST TOP PICK
(A Top Pick Aug 27/20, Up 40%) Trades at just over 14x earnings. Managed Covid expenses quite well. Excellent value here.
medical services
PAST TOP PICK
(A Top Pick Mar 20/20, Up 52%) Has owned it for a very long term. Second biggest health insurer. Provides health care insurers to individuals, corporations and governments. Gets best value for the money. Over time, has grown a lot. Biggest owners of Blue Cross and Blue Shield. Pays a nice growing dividend. Still undervalued here.
medical services
TOP PICK
Recent acquisition in Puerto Rico. Building out pharmacy benefit manager. Short-term volatility around commercial Medicaid. Very inexpensive. Decent growth. Less than 1 PEG ratio and visibility into that growth. Yield is 1.51%. (Analysts’ price target is $362.52)
medical services
TOP PICK
A large US health insurer (40 million Americans) and highly profitable. They'll make $26/share next year. Cheap at 12x earnings, and at least a 7% free cash flow. No, health insurance won't be in trouble when the Democrats take office, because about 170 million American hold private health insurance plans based on a 75% satisfaction rate. So, it's unlikely there'll be a radical change in American healthcare. (Analysts’ price target is $365.86)
medical services
PAST TOP PICK
(A Top Pick Aug 22/19, Up 5%) Has alliances with various companies and government. Successful. Commercial enrollments are down, as people are losing their jobs. However, medical loss ratios are positive because elective surgeries have been put off. Anticipates $26 EPS next year. Good cash flow.
medical services
Showing 1 to 15 of 101 entries

Anthem Inc(ANTM-N) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 8

Neutral - Hold Signals / Votes : 1

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 9

Stockchase rating for Anthem Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Anthem Inc(ANTM-N) Frequently Asked Questions

What is Anthem Inc stock symbol?

Anthem Inc is a American stock, trading under the symbol ANTM-N on the New York Stock Exchange (ANTM). It is usually referred to as NYSE:ANTM or ANTM-N

Is Anthem Inc a buy or a sell?

In the last year, 9 stock analysts published opinions about ANTM-N. 8 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Anthem Inc.

Is Anthem Inc a good investment or a top pick?

Anthem Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Anthem Inc.

Why is Anthem Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Anthem Inc worth watching?

9 stock analysts on Stockchase covered Anthem Inc In the last year. It is a trending stock that is worth watching.

What is Anthem Inc stock price?

On 2022-06-27, Anthem Inc (ANTM-N) stock closed at a price of $482.58.